dsip sbir Department of Defense Department of Defense (DoD) April
Description
We therefore quantified the extent to which the six subsamples overlapped with each other
DSIP inhibited hypothalamic somatostatin (SRIF) release in a dose-dependent fashion in rats
These findings underscore the importance of carefully selecting and dosing preservatives in intranasal drug delivery systems to balance efficacy with safety
Patients typically experience results for a year, though some find they want a boost around the 6 month mark, especially for those who had more severe symptoms before treatment
